Mavrilimumab | m-entrepreneurship.com

Product Name :
Mavrilimumab

Search keywords :
Mavrilimumab

drugId :
null

Target Vo:
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha

Target Vo Short Name :
CSF2RA

Moa_Name:
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Csl Ltd

Active Company_Name :
Huadong Medicine Co Ltd

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fibronectin Antibody
Aromatase Antibody
ERCC1 Antibody (YA770): ERCC1 Antibody (YA770) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to ERCC1 (7F6). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts